BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17028982)

  • 1. Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility: a case-control analysis.
    Huo X; Hu Z; Zhai X; Wang Y; Wang S; Wang X; Qin J; Chen W; Jin G; Liu J; Gao J; Wei Q; Wang X; Shen H
    Breast Cancer Res Treat; 2007 May; 102(3):329-37. PubMed ID: 17028982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
    Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between single nucleotide polymorphism of BARD1 gene and BRCA1 gene mutation in epithelial ovarian cancer].
    Liu WL; Zhao JZ; Wang ZZ; Dong B; Hou YY; Wu XX; Guo YJ
    Zhonghua Fu Chan Ke Za Zhi; 2017 Jun; 52(6):403-410. PubMed ID: 28647964
    [No Abstract]   [Full Text] [Related]  

  • 4. A cross-sectional study of associations between nonsynonymous mutations of the BARD1 gene and breast cancer in Han Chinese women.
    Liu H; Zhang H; Sun X; He Y; Li J; Guo X
    Asia Pac J Public Health; 2013 Jul; 25(4 Suppl):8S-14S. PubMed ID: 23966609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BARD1 Cys557Ser variant and breast cancer risk in Iceland.
    Stacey SN; Sulem P; Johannsson OT; Helgason A; Gudmundsson J; Kostic JP; Kristjansson K; Jonsdottir T; Sigurdsson H; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Bergthorsson JT; Amundadottir LT; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
    PLoS Med; 2006 Jul; 3(7):e217. PubMed ID: 16768547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BARD1 Cys557Ser variant and risk of familial breast cancer in a South-American population.
    Gonzalez-Hormazabal P; Reyes JM; Blanco R; Bravo T; Carrera I; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Santos JL; Jara L
    Mol Biol Rep; 2012 Aug; 39(8):8091-8. PubMed ID: 22544576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian families with high risk of breast cancer.
    Guénard F; Labrie Y; Ouellette G; Beauparlant CJ; Durocher F;
    J Hum Genet; 2009 Mar; 54(3):152-61. PubMed ID: 19197335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.
    Spurdle AB; Marquart L; McGuffog L; Healey S; Sinilnikova O; Wan F; Chen X; Beesley J; Singer CF; Dressler AC; Gschwantler-Kaulich D; Blum JL; Tung N; Weitzel J; Lynch H; Garber J; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Conroy D; Evans DG; Lalloo F; Eeles R; Izatt L; Davidson R; Chu C; Eccles D; Selkirk CG; Daly M; Isaacs C; Stoppa-Lyonnet D; Sinilnikova OM; Buecher B; Belotti M; Mazoyer S; Barjhoux L; Verny-Pierre C; Lasset C; Dreyfus H; Pujol P; Collonge-Rame MA; ; Rookus MA; Verhoef S; Kriege M; Hoogerbrugge N; Ausems MG; van Os TA; Wijnen J; Devilee P; Meijers-Heijboer HE; Blok MJ; Heikkinen T; Nevanlinna H; Jakubowska A; Lubinski J; Huzarski T; Byrski T; Durocher F; Couch FJ; Lindor NM; Wang X; Thomassen M; Domchek S; Nathanson K; Caligo M; Jernström H; Liljegren A; Ehrencrona H; Karlsson P; ; Ganz PA; Olopade OI; Tomlinson G; Neuhausen S; Antoniou AC; Chenevix-Trench G; Rebbeck TR
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1032-8. PubMed ID: 21393566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition.
    Vahteristo P; Syrjäkoski K; Heikkinen T; Eerola H; Aittomäki K; von Smitten K; Holli K; Blomqvist C; Kallioniemi OP; Nevanlinna H
    Eur J Hum Genet; 2006 Feb; 14(2):167-72. PubMed ID: 16333312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: a case-control analysis.
    Zhou X; Han S; Wang S; Chen X; Dong J; Shi X; Xia Y; Wang X; Hu Z; Shen H
    Gynecol Oncol; 2009 Aug; 114(2):327-31. PubMed ID: 19482343
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Rofes P; Del Valle J; Torres-Esquius S; Feliubadaló L; Stradella A; Moreno-Cabrera JM; López-Doriga A; Munté E; De Cid R; Campos O; Cuesta R; Teulé Á; Grau È; Sanz J; Capellá G; Díez O; Brunet J; Balmaña J; Lázaro C
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33498765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in exon region of BRCA1-related RING domain 1 gene and risk of breast cancer.
    Wu J; Aini A; Ma B
    Mol Genet Genomic Med; 2022 Mar; 10(3):e1847. PubMed ID: 35084806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations.
    Yu KD; Di GH; Li WF; Rao NY; Fan L; Yuan WT; Hu Z; Wu J; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2010 May; 121(1):157-67. PubMed ID: 19728081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of BARD1 in familial breast cancer patients in Japan.
    Ishitobi M; Miyoshi Y; Hasegawa S; Egawa C; Tamaki Y; Monden M; Noguchi S
    Cancer Lett; 2003 Oct; 200(1):1-7. PubMed ID: 14550946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies.
    Karppinen SM; Barkardottir RB; Backenhorn K; Sydenham T; Syrjäkoski K; Schleutker J; Ikonen T; Pylkäs K; Rapakko K; Erkko H; Johannesdottir G; Gerdes AM; Thomassen M; Agnarsson BA; Grip M; Kallioniemi A; Kere J; Aaltonen LA; Arason A; Møller P; Kruse TA; Borg A; Winqvist R
    J Med Genet; 2006 Nov; 43(11):856-62. PubMed ID: 16825437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BARD1 Gene Polymorphisms Confer Nephroblastoma Susceptibility.
    Fu W; Zhu J; Xiong SW; Jia W; Zhao Z; Zhu SB; Hu JH; Wang FH; Xia H; He J; Liu GC
    EBioMedicine; 2017 Feb; 16():101-105. PubMed ID: 28161399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.
    Thai TH; Du F; Tsan JT; Jin Y; Phung A; Spillman MA; Massa HF; Muller CY; Ashfaq R; Mathis JM; Miller DS; Trask BJ; Baer R; Bowcock AM
    Hum Mol Genet; 1998 Feb; 7(2):195-202. PubMed ID: 9425226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Literature Review of
    Alenezi WM; Fierheller CT; Recio N; Tonin PN
    Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32726901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BARD1 variants are not associated with breast cancer risk in Australian familial breast cancer.
    Gorringe KL; Choong DY; Visvader JE; Lindeman GJ; Campbell IG
    Breast Cancer Res Treat; 2008 Oct; 111(3):505-9. PubMed ID: 17972171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations.
    Ghimenti C; Sensi E; Presciuttini S; Brunetti IM; Conte P; Bevilacqua G; Caligo MA
    Genes Chromosomes Cancer; 2002 Mar; 33(3):235-42. PubMed ID: 11807980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.